Title of article - Discontinuing epidermal growth factor receptor-tyrosine kinase inhibitor during second-line chemotherapy: is the evidence strong enough?
Abstract
Late presentation of aortic false aneurysm following repair of acute type A aortic dissection occurs in 10% to 24% of cases. This condition is associated with high mortality if left untreated. Herein we describe a combination of surgical strategies that we believe may be used effectively to reduce the surgical risk of these complex operations.
CLICK HERE for Full article Click button above to go to original article link with complete article details for Discontinuing epidermal growth factor receptor-tyrosine kinase inhibitor during second-line chemotherapy: is the evidence strong enough?
Please CLICK HERE to discuss with us on facebook about this article.
Click below for Details of research Institute
1 Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China ; 2 Guangzhou Institute of Respiratory Disease & China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou 510120, China.
Details of Journal for Discontinuing epidermal growth factor receptor-tyrosine kinase inhibitor during second-line chemotherapy: is the evidence strong enough?
Journal Title - Annals of translational medicine
ISSN - 2305-5839
Volume - 3
Issue - 14
Publish date - 2015-Aug
Language - eng
Country - China
No comments:
Post a Comment